Amit M. Algotar, Ph.D.
Affiliations: | 2008 | Epidemiology | University of Arizona, Tucson, AZ |
Area:
Epidemiology, Oncology, Public HealthGoogle:
"Amit Algotar"Cross-listing: PHTree
Parents
Sign in to add mentor| James Ranger-Moore | grad student | 2008 | University of Arizona | |
| (Risk factors for prostate cancer progression.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sun BL, Sun X, Casanova N, et al. (2020) Role of secreted extracellular nicotinamide phosphoribosyltransferase (eNAMPT) in prostate cancer progression: Novel biomarker and therapeutic target. Ebiomedicine. 61: 103059 |
| Algotar A, Hsu CH, Sherry Chow HH, et al. (2019) Comprehensive Lifestyle Improvement Program for Prostate Cancer (CLIPP): Protocol for a Feasibility and Exploratory Efficacy Study in Men on Androgen Deprivation Therapy. Jmir Research Protocols. 8: e12579 |
| Algotar AM, Algotar K, Berkowitz A, et al. (2018) Disconnect between physical activity guidelines and ground reality: A real world analysis of physical activity profile of cancer survivors. Journal of Clinical Oncology. 36: 105-105 |
| Fletcher S, Alsaid N, Katragadda C, et al. (2018) Risk of biochemical recurrence (BCR) in prostate cancer (PCa) patients (pts) with perineural invasion (PNI): Systematic review and meta-analysis. Journal of Clinical Oncology. 36: e17060-e17060 |
| Algotar AM, Singh P, Billins J, et al. (2016) Change in prostate biopsy outcomes and costs of care for prostate cancer in underserved population after changes in USPSTF guidelines. Journal of Clinical Oncology. 34: 1548-1548 |
| Algotar AM, Behnejad R, Singh P, et al. (2015) EFFECT OF SELENIUM SUPPLEMENTATION ON PROTEOMIC SERUM BIOMARKERS IN ELDERLY MEN. The Journal of Frailty & Aging. 4: 107-110 |
| Algotar A, Cress A, Nagle R, et al. (2015) Association of ERG-PTEN expression profile of prostate biopsy with PSA velocity. Journal of Clinical Oncology. 33: 92-92 |
| Algotar AM, Cress A, Nagle R, et al. (2015) DNA damage and repair markers to improve accuracy of prostate cancer diagnosis and identification of aggressive disease. Journal of Clinical Oncology. 33: e16012-e16012 |
| Algotar AM, Behnejad R, Stratton MS, et al. (2015) Can smoking lead to delay in diagnosis of prostate cancer Journal of Clinical Oncology. 33 |
| Algotar AM, Behnejad R, Stratton MS, et al. (2014) Chronic use of NSAIDs and/or statins does not affect PSA or PSA velocity in men at high risk for prostate cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 2196-8 |